Global changes to the ubiquitin system in Huntington's disease

被引:403
作者
Bennett, Eric J.
Shaler, Thomas A.
Woodman, Ben
Ryu, Kwon-Yul
Zaitseva, Tatiana S.
Becker, Christopher H.
Bates, Gillian P.
Schulman, Howard
Kopito, Ron R. [1 ]
机构
[1] Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA
[2] PPD Biomarker Discovery Inc, Menlo Pk, CA 94025 USA
[3] Kings Coll London, Sch Med, Dept Med & Mol Genet, London SE1 9RT, England
基金
英国惠康基金;
关键词
D O I
10.1038/nature06022
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Huntington's disease (HD) is a dominantly inherited neuro-degenerative disorder caused by expansion of CAG triplet repeats in the huntingtin (HTT) gene (also called HD) and characterized by accumulation of aggregated fragments of polyglutamine-expanded HTT protein in affected neurons(1,2). Abnormal enrichment of HD inclusion bodies with ubiquitin, a diagnostic characteristic of HD and many other neurodegenerative disorders including Alzheimer's and Parkinson's diseases(3,4), has suggested that dysfunction in ubiquitin metabolism may contribute to the pathogenesis of these diseases(5,6). Because modification of proteins with polyubiquitin chains regulates many essential cellular processes including protein degradation, cell cycle, transcription, DNA repair and membrane trafficking(7), disrupted ubiquitin signalling is likely to have broad consequences for neuronal function and survival. Although ubiquitin-dependent protein degradation is impaired in cell-culture models of HD8-11 and of other neurodegenerative diseases(12,13), it has not been possible to evaluate the function of the ubiquitin-proteasome system (UPS) in HD patients or in animal models of the disease, and a functional role for UPS impairment in neurodegenerative disease pathogenesis remains controversial(14-16). Here we exploit a mass-spectrometry-based method to quantify polyubiquitin chains(17) and demonstrate that the abundance of these chains is a faithful endogenous biomarker of UPS function. Lys 48-linked polyubiquitin chains accumulate early in pathogenesis in brains from the R6/2 transgenic mouse model of HD, from a knock-in model of HD and from human HD patients, establishing that UPS dysfunction is a consistent feature of HD pathology. Lys 63- and Lys 11-linked polyubiquitin chains, which are not typically associated with proteasomal targeting, also accumulate in the R6/2 mouse brain. Thus, HD is linked to global changes in the ubiquitin system to a much greater extent than previously recognized.
引用
收藏
页码:704 / U11
页数:6
相关论文
共 28 条
[11]   Quantitative analysis of in vitro ubiquitinated cyclin B1 reveals complex chain topology [J].
Kirkpatrick, Donald S. ;
Hathaway, Nathaniel A. ;
Hanna, John ;
Elsasser, Suzanne ;
Rush, John ;
Finley, Daniel ;
King, Randall W. ;
Gygi, Steven P. .
NATURE CELL BIOLOGY, 2006, 8 (07) :700-U121
[12]   Monitoring activity and inhibition of 26S proteasomes with fluorogenic peptide substrates [J].
Kisselev, AF ;
Goldberg, A .
UBIQUITIN AND PROTEIN DEGRADATION, PART A, 2005, 398 :364-378
[13]   Neurological abnormalities in a knock-in mouse model of Huntington's disease [J].
Lin, CH ;
Tallaksen-Greene, S ;
Chien, WM ;
Cearley, JA ;
Jackson, WS ;
Crouse, AB ;
Ren, SR ;
Li, XJ ;
Albin, RL ;
Detloff, PJ .
HUMAN MOLECULAR GENETICS, 2001, 10 (02) :137-144
[14]   A transgenic mouse model of the ubiquitin/proteasome system [J].
Lindsten, K ;
Menéndez-Benito, V ;
Masucci, MG ;
Dantuma, NP .
NATURE BIOTECHNOLOGY, 2003, 21 (08) :897-902
[15]   UBIQUITIN IS A COMMON FACTOR IN INTERMEDIATE FILAMENT INCLUSION-BODIES OF DIVERSE TYPE IN MAN, INCLUDING THOSE OF PARKINSONS-DISEASE, PICKS DISEASE, AND ALZHEIMERS-DISEASE, AS WELL AS ROSENTHAL FIBERS IN CEREBELLAR ASTROCYTOMAS, CYTOPLASMIC BODIES IN MUSCLE, AND MALLORY BODIES IN ALCOHOLIC LIVER-DISEASE [J].
LOWE, J ;
BLANCHARD, A ;
MORRELL, K ;
LENNOX, G ;
REYNOLDS, L ;
BILLETT, M ;
LANDON, M ;
MAYER, RJ .
JOURNAL OF PATHOLOGY, 1988, 155 (01) :9-15
[16]   A NOVEL GENE CONTAINING A TRINUCLEOTIDE REPEAT THAT IS EXPANDED AND UNSTABLE ON HUNTINGTONS-DISEASE CHROMOSOMES [J].
MACDONALD, ME ;
AMBROSE, CM ;
DUYAO, MP ;
MYERS, RH ;
LIN, C ;
SRINIDHI, L ;
BARNES, G ;
TAYLOR, SA ;
JAMES, M ;
GROOT, N ;
MACFARLANE, H ;
JENKINS, B ;
ANDERSON, MA ;
WEXLER, NS ;
GUSELLA, JF ;
BATES, GP ;
BAXENDALE, S ;
HUMMERICH, H ;
KIRBY, S ;
NORTH, M ;
YOUNGMAN, S ;
MOTT, R ;
ZEHETNER, G ;
SEDLACEK, Z ;
POUSTKA, A ;
FRISCHAUF, AM ;
LEHRACH, H ;
BUCKLER, AJ ;
CHURCH, D ;
DOUCETTESTAMM, L ;
ODONOVAN, MC ;
RIBARAMIREZ, L ;
SHAH, M ;
STANTON, VP ;
STROBEL, SA ;
DRATHS, KM ;
WALES, JL ;
DERVAN, P ;
HOUSMAN, DE ;
ALTHERR, M ;
SHIANG, R ;
THOMPSON, L ;
FIELDER, T ;
WASMUTH, JJ ;
TAGLE, D ;
VALDES, J ;
ELMER, L ;
ALLARD, M ;
CASTILLA, L ;
SWAROOP, M .
CELL, 1993, 72 (06) :971-983
[17]   Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice [J].
Mangiarini, L ;
Sathasivam, K ;
Seller, M ;
Cozens, B ;
Harper, A ;
Hetherington, C ;
Lawton, M ;
Trottier, Y ;
Lehrach, H ;
Davies, SW ;
Bates, GP .
CELL, 1996, 87 (03) :493-506
[18]  
Mayer R J, 1989, Prog Clin Biol Res, V317, P809
[19]   Parkin protects against the toxicity associated with mutant α-synuclein:: Proteasome dysfunction selectively affects catecholaminergic neurons [J].
Petrucelli, L ;
O'Farrell, C ;
Lockhart, PJ ;
Baptista, M ;
Kehoe, K ;
Vink, L ;
Choi, P ;
Wolozin, B ;
Farrer, M ;
Hardy, J ;
Cookson, MR .
NEURON, 2002, 36 (06) :1007-1019
[20]   Polyubiquitin chains: polymeric protein signals [J].
Pickart, CM ;
Fushman, D .
CURRENT OPINION IN CHEMICAL BIOLOGY, 2004, 8 (06) :610-616